Abstract
Circulating cardiac troponin (cTn) concentrations have become an increasingly important biomarker for the noninvasive detection of myocardial injury in many cardiovascular diseases, in particular, patients with coronary heart disease presenting with acute chest pain (1).
Cite
CITATION STYLE
APA
Ni, L., & Wehren, X. H. T. (2018). Cardiac troponin I—more than a biomarker for myocardial ischemia? Annals of Translational Medicine, 6(S1), S17–S17. https://doi.org/10.21037/atm.2018.09.07
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free